
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
RFC1 CRISPR/Cas9 KO Plasmid (h2) | sc-402122-KO-2 | 20 µg | $397.00 | |||
RFC1 HDR Plasmid (h2) | sc-402122-HDR-2 | 20 µg | $445.00 |
RFC1 encodes replication factor C subunit 1, the large subunit of the heteropentameric RFC complex that loads PCNA onto primed DNA to promote processive DNA synthesis. RFC1 is integral to DNA replication and multiple DNA repair pathways, including mismatch repair and nucleotide excision repair, and it contributes to genome stability by coordinating checkpoint and post-replicative repair processes. Perturbation of RFC1-dependent clamp loading can disrupt S-phase progression, replication fork dynamics, and responses to replication stress. Altered RFC1 activity is therefore relevant to mechanistic studies of genomic instability phenotypes observed across diverse disorders and cancer-associated cellular states.
RFC1 CRISPR/Cas9 KO Plasmid (h2) is a pool of plasmids designed for targeted disruption of the RFC1 gene in human cell lines. Each plasmid in the pool co-expresses a unique sgRNA, targeting a distinct site within the RFC1 locus, alongside the Streptococcus pyogenes Cas9 nuclease, and encodes GFP to enable fluorescent identification and enrichment of successfully transfected cells. This multi-guide strategy increases the likelihood of inducing frameshifts or deletions that produce a functional knockout, offering a more robust alternative to single-guide approaches. DSBs induced at multiple sites are resolved through non-homologous end joining (NHEJ) or, when used with the included HDR donor template, homology-directed repair (HDR) at a defined target site within the locus.
When used in conjunction with the RFP-expressing HDR donor, GFP and RFP fluorescence can be used together to distinguish transfected from edited cell populations, streamlining flow cytometry-based sorting and clone selection workflows.
For applications requiring confirmed, selectable knockout clones, RFC1 HDR Plasmid (h2) includes an HDR donor construct containing a puromycin resistance cassette (PuroR) and a red fluorescent protein (RFP) reporter, flanked by homology arms specific to a defined RFC1 target site.
When co-transfected with RFC1 CRISPR/Cas9 KO Plasmid (h2):
The HDR donor construct features loxP sites flanking the PuroR-RFP selection cassette to allow clean marker removal following clone confirmation. Transient expression of Cre recombinase via the included Cre Vector: sc-418923 excises the cassette, leaving a minimal residual loxP site within the RFC1 locus and eliminating potential confounding effects on downstream assays.
This two-step approach:
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.